Sewoon Medical Co., Ltd (KOSDAQ:100700)
2,430.00
-30.00 (-1.22%)
At close: Sep 3, 2026
Sewoon Medical Revenue
Sewoon Medical had revenue of 17.71B KRW in the quarter ending June 30, 2026, with 13.02% growth. This brings the company's revenue in the last twelve months to 66.53B, up 10.39% year-over-year. In the year 2025, Sewoon Medical had annual revenue of 63.66B with 5.83% growth.
Revenue (ttm)
66.53B
Revenue Growth
+10.39%
P/S Ratio
1.57
Revenue / Employee
382.35M
Employees
172
Market Cap
104.18B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.66B | 3.51B | 5.83% |
| Dec 31, 2024 | 60.15B | -8.10B | -11.86% |
| Dec 31, 2023 | 68.25B | 8.13B | 13.53% |
| Dec 31, 2022 | 60.12B | -2.46B | -3.94% |
| Dec 31, 2021 | 62.58B | -1.15B | -1.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 144.10B |
| JW Shinyak | 81.04B |
| CG MedTech | 51.20B |
| OSTEONIC | 50.97B |
| DuChemBIO | 41.51B |
| Wonbiogen | 37.80B |
| SCL Science | 30.50B |
| Plasmapp | 12.02B |